View in EDS

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.

Saved in:
Bibliographic Details
Title: Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
Authors: Bogen D; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Wei JS; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Azorsa DO; Clinical Translational Research Division, Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA., Ormanoglu P; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Buehler E; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Guha R; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Keller JM; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Mathews Griner LA; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Song YK; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Liao H; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mendoza A; Tumor and Metastasis Biology Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gryder BE; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sindri S; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., He J; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Wen X; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zhang S; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Shern JF; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yohe ME; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Taschner-Mandl S; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Shohet JM; Texas Children's Cancer Center and Center for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Martin SE; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Ambros PF; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Khan J; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Source: Oncotarget [Oncotarget] 2015 Nov 03; Vol. 6 (34), pp. 35247-62.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26497213
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bogen+D%22">Bogen D</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Wei+JS%22">Wei JS</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Azorsa+DO%22">Azorsa DO</searchLink>; Clinical Translational Research Division, Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Ormanoglu+P%22">Ormanoglu P</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Buehler+E%22">Buehler E</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Guha+R%22">Guha R</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Keller+JM%22">Keller JM</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mathews+Griner+LA%22">Mathews Griner LA</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ferrer+M%22">Ferrer M</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Song+YK%22">Song YK</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Liao+H%22">Liao H</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mendoza+A%22">Mendoza A</searchLink>; Tumor and Metastasis Biology Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gryder+BE%22">Gryder BE</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sindri+S%22">Sindri S</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22He+J%22">He J</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wen+X%22">Wen X</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shern+JF%22">Shern JF</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yohe+ME%22">Yohe ME</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Taschner-Mandl+S%22">Taschner-Mandl S</searchLink>; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Shohet+JM%22">Shohet JM</searchLink>; Texas Children's Cancer Center and Center for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+CJ%22">Thomas CJ</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Martin+SE%22">Martin SE</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ambros+PF%22">Ambros PF</searchLink>; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Khan+J%22">Khan J</searchLink>; Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2015 Nov 03; Vol. 6 (34), pp. 35247-62.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26497213
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.6208
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 35247
    Titles:
      – TitleFull: Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bogen D
      – PersonEntity:
          Name:
            NameFull: Wei JS
      – PersonEntity:
          Name:
            NameFull: Azorsa DO
      – PersonEntity:
          Name:
            NameFull: Ormanoglu P
      – PersonEntity:
          Name:
            NameFull: Buehler E
      – PersonEntity:
          Name:
            NameFull: Guha R
      – PersonEntity:
          Name:
            NameFull: Keller JM
      – PersonEntity:
          Name:
            NameFull: Mathews Griner LA
      – PersonEntity:
          Name:
            NameFull: Ferrer M
      – PersonEntity:
          Name:
            NameFull: Song YK
      – PersonEntity:
          Name:
            NameFull: Liao H
      – PersonEntity:
          Name:
            NameFull: Mendoza A
      – PersonEntity:
          Name:
            NameFull: Gryder BE
      – PersonEntity:
          Name:
            NameFull: Sindri S
      – PersonEntity:
          Name:
            NameFull: He J
      – PersonEntity:
          Name:
            NameFull: Wen X
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Shern JF
      – PersonEntity:
          Name:
            NameFull: Yohe ME
      – PersonEntity:
          Name:
            NameFull: Taschner-Mandl S
      – PersonEntity:
          Name:
            NameFull: Shohet JM
      – PersonEntity:
          Name:
            NameFull: Thomas CJ
      – PersonEntity:
          Name:
            NameFull: Martin SE
      – PersonEntity:
          Name:
            NameFull: Ambros PF
      – PersonEntity:
          Name:
            NameFull: Khan J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2015 Nov 03
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 34
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1